Survival of a cemented porous-coated prosthesis

Porous-surfaced femoral components were approved by the United States Food and Drug Administration for implantation with polymethyl methacrylate cement in total hip arthroplasty. The ability of porous coating to prevent loosening of prostheses in vivo has not been reported in the literature previously. This study compared the radiographic and clinical success of two structurally similar prosthetic designs, one of which incorporates a porous coat. Kaplan-Meier survival analysis showed no significant difference between the components (P greater than .05) when failure is defined as revision alone, radiolucency alone, or the combination of revision and radiolucency.